AFFIMED N V's ticker is AFMD and the CUSIP is N01045108. A total of 92 filers reported holding AFFIMED N V in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,691,000 | -25.6% | 821,065 | 0.0% | 0.54% | -37.1% |
| Q2 2022 | $2,274,000 | -19.2% | 821,065 | +27.6% | 0.85% | -8.3% |
| Q1 2022 | $2,813,000 | -53.7% | 643,664 | -9.9% | 0.93% | -38.3% |
| Q2 2021 | $6,074,000 | +40.1% | 714,576 | +30.4% | 1.51% | +71.6% |
| Q1 2021 | $4,335,000 | +40.3% | 548,044 | -39.9% | 0.88% | +43.8% |
| Q3 2020 | $3,089,000 | -28.3% | 911,279 | -2.3% | 0.61% | -51.3% |
| Q2 2020 | $4,306,000 | +167.6% | 933,150 | -8.4% | 1.26% | +133.2% |
| Q1 2020 | $1,609,000 | -42.3% | 1,018,200 | 0.0% | 0.54% | -18.9% |
| Q4 2019 | $2,790,000 | +262.8% | 1,018,200 | +280.0% | 0.66% | +259.5% |
| Q2 2019 | $769,000 | -31.6% | 267,942 | 0.0% | 0.18% | -39.1% |
| Q1 2019 | $1,125,000 | +123.7% | 267,942 | +65.8% | 0.30% | +66.1% |
| Q4 2018 | $503,000 | -79.3% | 161,635 | -71.0% | 0.18% | -78.0% |
| Q3 2018 | $2,426,000 | – | 557,615 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Public Equity Management, LLC | 3,209,013 | $6,578,000 | 0.40% |
| Telemetry Investments, L.L.C. | 367,067 | $752,000 | 0.35% |
| NEA Management Company, LLC | 3,888,888 | $7,972,000 | 0.29% |
| DAFNA Capital Management LLC | 92,500 | $190,000 | 0.14% |
| Tekla Capital Management LLC | 1,405,324 | $2,881,000 | 0.11% |
| Perceptive Advisors | 668,214 | $1,369,000 | 0.07% |
| MUHLENKAMP & CO INC | 72,786 | $149,000 | 0.05% |
| Orbimed Advisors | 1,799,700 | $3,689,000 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 250,000 | $513,000 | 0.02% |
| Baker Brothers Advisors | 400,000 | $820,000 | 0.01% |